Limited studies have explored the association between pharmacotherapy treatment and socio-behavioral and employment-related difficulties among adults with ADHD in U.S. This study aimed to evaluate and compare socio-behavioral and employment outcomes among adults with ADHD who were receiving stimulant treatment versus those who were not.
Methods:
A retrospective cross-sectional study was conducted using the Medical Expenditure Panel Survey data from 2013-2019. Adults with ADHD were categorized into stimulant-treated versus not stimulant-treated groups. Multivariable logistic regression was utilized to assess the association between stimulant use and outcomes of interest (e.g., social, behavioral, and employment outcomes) and was reported using odds ratio (ORs). Propensity score matching was used to control for confounding and sub-group analyses were conducted by adherence to CNS stimulants.
Results:
Among 1,290 (2,468,186 weighted) patients, 80.67% were stimulant-treated, and 19.33% were not treated with stimulants. No significant differences were found in the employment outcomes between the two groups in adjusted models. Sub-group analyses showed that adherent users of stimulants had higher odds of self-employment (OR = 2.10 [1.15, 3.82]) than non-adherent users. Stimulant-treated adults had higher odds of social limitations (OR = 3.16 [1.50, 6.69]), and lower odds of physical activity (OR = 0.29 [0.13, 0.66]) compared to those who were not treated with stimulants.
Conclusion:
Overall, these findings highlight important gaps in understanding the relationship between real-world functional outcomes and stimulants use in adults with ADHD and underscore the need for additional longitudinal and real-world studies to thoroughly understand the impact of ADHD medications on those outcomes.
AdlerL. A.DirksB.DeasP.RaychaudhuriA.DauphinM.SaylorK.WeislerR. (2013). Self-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: A randomized, double-blind, multicenter, placebo-controlled, parallel-group study. BMC Psychiatry, 13, 253. https://doi.org/10.1186/1471-244X-13-253
AlthubaitiA. (2016). Information bias in health research: Definition, pitfalls, and adjustment methods. Journal of Multidisciplinary Healthcare, 9, 211–217. https://doi.org/10.2147/JMDH.S104807
6.
AshersonP.AkehurstR.KooijJ. J. S.HussM.BeusterienK.SasanéR.GholizadehS.HodgkinsP. (2012). Under diagnosis of adult ADHD: Cultural influences and societal burden. Journal of Attention Disorders, 16(5), 20S–38S. https://doi.org/10.1177/1087054711435360
7.
AustinP. C. (2010). Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score. American Journal of Epidemiology, 172(9), 1092–1097. https://doi.org/10.1093/AJE/KWQ224
8.
AustinP. C. (2011). An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behavioral Research, 46(3), 399–424. https://doi.org/10.1080/00273171.2011.568786
9.
BjörkA.RönngrenY.SelanderJ.VinbergS.HellzenO.OlofssonN. (2018). Health, lifestyle habits, and physical fitness among adults with ADHD compared with a random sample of a Swedish general population. Society, Health & Vulnerability, 9(1), Article 1553916. https://doi.org/10.1080/20021518.2018.1553916
10.
BlewettL. A.Rivera DrewJ. A.BackmanD.ChenA.CooperG.SchouweilerM.RichardsS. (2024). IPUMS health surveys: Medical expenditure panel survey (Version 2.4) [Data set]. IPUMS. https://doi.org/10.18128/D071.V2.4
11.
CabralM. D. I.LiuS.SoaresN. (2020). Attention-deficit/hyperactivity disorder: Diagnostic criteria, epidemiology, risk factors and evaluation in youth. Translational Pediatrics, 9(1), S104–S113. https://doi.org/10.21037/TP.2019.09.08
12.
CoghillD. R.BanaschewskiT.SoutulloC.CottinghamM. G.ZuddasA. (2017). Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder. European Child & Adolescent Psychiatry, 26(11), 1283–1307. https://doi.org/10.1007/S00787-017-0986-Y
13.
CummingsJ. R.JiX.AllenL.LallyC.DrussB. G. (2017). Racial and ethnic differences in ADHD treatment quality among medicaid-enrolled youth. Pediatrics, 139(6). https://doi.org/10.1542/PEDS.2016-2444
ForbesC. A.DeshpandeS.Sorio-VilelaF.KutikovaL.DuffyS.Gouni-BertholdI.HagströmE. (2018). A systematic literature review comparing methods for the measurement of patient persistence and adherence. Current Medical Research and Opinion, 34(9), 1613–1625. https://doi.org/10.1080/03007995.2018.1477747
FrenchB.DaleyD.GroomM.CassidyS. (2023). Risks associated with undiagnosed ADHD and/or autism: A mixed-method systematic review. Journal of Attention Disorders, 27(12), 1393–1410. https://doi.org/10.1177/10870547231176862
18.
GinsbergY.QuinteroJ.AnandE.CasillasM.UpadhyayaH. P. (2014). Underdiagnosis of attention-deficit/hyperactivity disorder in adult patients: A review of the literature. The Primary Care Companion for CNS Disorders, 16(3). https://doi.org/10.4088/PCC.13R01600
GreiferN. (2025, January12). Matching with sampling weights. Github.Io.
21.
HalmøyA.FasmerO. B.GillbergC.HaavikJ. (2009). Occupational outcome in adult ADHD: Impact of symptom profile, comorbid psychiatric problems, and treatment: a cross-sectional study of 414 clinically diagnosed adult ADHD patients. Journal of Attention Disorders, 13(2), 175–187. https://doi.org/10.1177/1087054708329777
22.
HansenB. B.KlopferS. O. (2006). Optimal full matching and related designs via network flows. Journal of Computational and Graphical Statistics, 15(3), 609–627. https://doi.org/10.1198/106186006X137047
23.
HoD.ImaiK.KingG.StuartE. A. (2011). MatchIt: Nonparametric preprocessing for parametric causal inference. Journal of Statistical Software, 42(8), 1–28.
JeunK. J.NduagubaS.Al-MamunM. A. (2024). Factors influencing medication adherence in adults with attention-deficit/hyperactivity disorder (ADHD) and its impact on healthcare utilization. Journal of Attention Disorders, 28(2), 168–177. https://doi.org/10.1177/10870547231210284
KisB.LückeC.Abdel-HamidM.HeβmannP.GrafE.BergerM.MatthiesS.BorelP.SobanskiE.AlmB.RöslerM.RetzW.JacobC.CollaM.HussM.JansT.Van ElstL. T.MüllerH. H. O.PhilipsenA. (2020). Safety profile of methylphenidate under long-term treatment in adult ADHD patients - Results of the COMPAS study. Pharmacopsychiatry, 53(6), 263–271. https://doi.org/10.1055/A-1207-9851
KooijJ. J. S.RöslerM.PhilipsenA.WächterS.DejonckheereJ.van der KolkA.van AgthovenM.SchäubleB. (2013). Predictors and impact of non-adherence in adults with attention-deficit/hyperactivity disorder receiving OROS methylphenidate: Results from a randomized, placebo-controlled trial. BMC Psychiatry, 13, 36. https://doi.org/10.1186/1471-244X-13-36
30.
KosheleffA. R.MasonO.JainR.KochJ.RubinJ. (2023). Functional impairments associated with ADHD in adulthood and the impact of pharmacological treatment. Journal of Attention Disorders, 27(7), 669–697. https://doi.org/10.1177/10870547231158572
31.
LeeL.ArunajadaiS.MiklJ.ErensenJ. G.GoodmanD. W. (2023). The burden of attention-deficit/hyperactivity disorder in adults: A real-world linked data study. The Primary Care Companion for CNS Disorders, 25(2). https://doi.org/10.4088/PCC.22M03348
32.
LiL.ChangZ.SunJ.JangmoA.ZhangL.AnderssonL. M.Werner-KiechleT.AhnemarkE.D’OnofrioB. M.LarssonH. (2022). Association between pharmacological treatment of attention-deficit/hyperactivity disorder and long-term unemployment among working-age individuals in Sweden. JAMA Network Open, 5(4), E226815. https://doi.org/10.1001/jamanetworkopen.2022.6815
PallantiS.SalernoL. (2020). The burden of adult ADHD in comorbid psychiatric and neurological disorders. Springer Nature Switzerland AG.
39.
ParkinR.NicholasF. M.HaydenJ. C. (2022). A systematic review of interventions to enhance adherence and persistence with ADHD pharmacotherapy. Journal of Psychiatric Research, 152, 201–218. https://doi.org/10.1016/J.JPSYCHIRES.2022.05.044
40.
PawaskarM.FridmanM.GreblaR.MadhooM. (2020). Comparison of quality of life, productivity, functioning and self-esteem in adults diagnosed with ADHD and with symptomatic ADHD. Journal of Attention Disorders, 24(1), 136–144. https://doi.org/10.1177/1087054719841129
PostR. E.KurlansikS. L. (2012). Diagnosis and management of adult attention-deficit/hyperactivity disorder. American Family Physician, 85(9), 890–896. https://pubmed.ncbi.nlm.nih.gov/22612184/
43.
Prieto-MerinoD.MulickA.ArmstrongC.HoultH.FawcettS.EliassonL.CliffordS. (2021). Estimating proportion of days covered (PDC) using real-world online medicine suppliers’ datasets. Journal of Pharmaceutical Policy and Practice, 14(1), 113. https://doi.org/10.1186/S40545-021-00385-W
44.
R Core Team. (2023). R: A language and environment for statistical computing [Computer software]. R Foundation for Statistical Computing.
45.
SAS Institute Inc. (2013). SAS software (Version 9.4) [Computer software]..
46.
ScheinJ.AdlerL. A.ChildressA.Gagnon-SanschagrinP.DavidsonM.KinkeadF.CloutierM.GuérinA.LefebvreP. (2022). Economic burden of attention-deficit/hyperactivity disorder among adults in the United States: A societal perspective. Journal of Managed Care & Specialty Pharmacy, 28(2), 168–179. https://doi.org/10.18553/JMCP.2021.21290
47.
ScheinJ.CloutierM.Gauthier-LoiselleM.BungayR.GuerinA.ChildressA. (2023). Symptoms associated with ADHD/treatment-related adverse side effects and their impact on quality of life and work productivity in adults with ADHD. Current Medical Research and Opinion, 39(1), 149–159. https://doi.org/10.1080/03007995.2022.2122228
48.
ShahC. H.BalkrishnanR.DiabyV.XiaoH. (2020). Examining factors associated with adherence to hormonal therapy in breast cancer patients. Research in Social & Administrative Pharmacy, 16(4), 574–582. https://doi.org/10.1016/J.SAPHARM.2019.08.005
49.
SpaldingW.FarahbakhshianS.MaculaitisM. C.PeckE. Y.GorenA. (2022). The Association of oral stimulant medication adherence with work productivity among adults with ADHD. Journal of Attention Disorders, 26(6), 831–842. https://doi.org/10.1177/10870547211020113
50.
StevensJ. R.WilensT. E.SternT. A. (2013). Using stimulants for attention-deficit/hyperactivity disorder: Clinical approaches and challenges. The Primary Care Companion for CNS Disorders, 15(2). https://doi.org/10.4088/PCC.12F01472
51.
SurmanC. B. H.HammernessP. G.PionK.FaraoneS. V. (2013). Do stimulants improve functioning in adults with ADHD? A review of the literature. European Neuropsychopharmacology, 23(6), 528–533. https://doi.org/10.1016/J.EURONEURO.2012.02.010
52.
TaipaleH.BergströmJ.GèmesK.TanskanenA.EkseliusL.Mittendorfer-RutzE.HelgessonM. (2024). Attention-Deficit/Hyperactivity Disorder medications and work disability and mental health outcomes. JAMA Network Open, 7(3), E242859. https://doi.org/10.1001/JAMANETWORKOPEN.2024.2859
53.
van StralenJ.ParharG.ParharA.TourjmanV.KhattakS.AhmedT.DonnellyG. A. E.RatzJ. (2023). Real-world efficacy and safety of extended-release methylphenidate (PRC-063) in the treatment of ADHD in pediatric and adult subjects: Results of a phase IV multicenter comparison with lisdexamfetamine dimesylate. Journal of Attention Disorders, 27(7), 743–756. https://doi.org/10.1177/10870547231172767
WilensT. E.SpencerT. J. (2010). Understanding attention-deficit/hyperactivity disorder from childhood to adulthood. Postgraduate Medicine, 122(5), 97–109. https://doi.org/10.3810/PGM.2010.09.2206
57.
YoungJ. L.GoodmanD. W. (2016). Adult Attention-Deficit/Hyperactivity Disorder diagnosis, management, and treatment in the DSM-5 era. The Primary Care Companion for CNS Disorders, 18(6). https://doi.org/10.4088/PCC.16R02000
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
